CD4 and myeloid sarcoma: We show that PBMC from MS and healthy (HI) donors rapidly engraft B2m-NOG mice with human (h) CD4+ and hCD8+ T and B cells, with donor-specific differences toward proportions of human immune cell populations engrafted and propensity to develop CNS inflammation.